...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Role of Micro Emulsion Based In-Situ Gelling System of Fluoroquinolone for Treatment of Posterior Segment Eye Diseases (PSED)
【24h】

Role of Micro Emulsion Based In-Situ Gelling System of Fluoroquinolone for Treatment of Posterior Segment Eye Diseases (PSED)

机译:微乳液基原位胶凝系统的作用氟喹诺酮治疗后段眼疾病(PSED)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The in situ drug delivery system and colloidal formulation like micro emulsion has potential to use in ocular delivery. Micro emulsion provides better permeation of drug through the membrane and provides improved bioavailability. The in situ drug delivery system decreases pre-corneal drainage, increase the contact time of formulation with eye and prolong the release in ocular tissues. Again, in situ gelling system has advantage of delivering accurate and reproducible quantities each time, against any already gelled formulations. To combine the benefits of these two dosage forms, micro emulsion based in situ gelling system can be developed as a novel vehicle for ophthalmic drug delivery. Endophthalmitis is an infection of intraocular fluids like vitreous humor and ocular tissues. To combat the disease, the formulation which provides sufficient concentration in posterior segment eye diseases?(PSED) is required.
机译:原位药物递送系统和胶体制剂​​如微乳液具有潜力可用于眼部递送。微乳液通过膜提供更好的药物渗透性,并提供改善的生物利用度。原位药物递送系统降低了前角膜排水,增加了眼睛配方的接触时间,延长了眼组织中的释放。同样,原位胶凝系统具有每次提供准确和可再现的量的优点,而不是任何已经凝胶化的配方。为了结合这两种剂型的益处,可以将溶于原位胶凝系统的微乳液作为眼科药物递送的新载体。眼镜炎是一种人眼内液体,如玻璃体液体和眼部组织。为了对抗这种疾病,在后部段疾病中提供足够浓度的制剂是必需的?(PSED)是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号